NQO1 and cancer: This NQO1-dependent cycling of β-lap appears to be especially prominent in cancer cells, since such cells are reported to contain higher activities of NQO1 than non-cancerous cells, which supports the potential use of β-lap as an anti-cancer drug [1, 14].